ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1256

Quantitative Analysis of a Pilot Study: Integrating Behavioral Health Services for Patients with Rheumatic Diseases

Shannon Teaw1, Jessica Link-Malcolm2, Michelle Ghebranious Farag3, Dorothy Patterson2, Jenny Foster4, Sofia Bereket2, Urooj Wahid2, Puneet Bajaj2, Elizabeth Solow2, Jennifer Barton5 and Una Makris6, 1UT Southwestern Medical School, Dallas, TX, 2UT Southwestern Medical Center, Dallas, TX, 3McGovern Medical School at UT Houston, Houston, TX, 4UT Southwestern Medical Center, Dallas, 5VA Portland Health Care System/OHSU, Portland, OR, 6UT Southwestern Medical Center and Dallas VA, Dallas, TX

Meeting: ACR Convergence 2025

Keywords: health behaviors, Health Services Research, mental health, pain, physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1248–1271) Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with rheumatic diseases (RD) often experience chronic pain, along with comorbid depression and anxiety, which can be addressed using behavioral health (BH) interventions for motivating behavior change and increasing self-management skills. Despite potential benefits, efforts to integrate BH services into rheumatology clinics have been limited. We developed and piloted a single-arm BH program integrated within a rheumatology clinic to evaluate feasibility and trends towards improved patient-reported outcomes (PRO).

Methods: During their clinic visit, adult patients with RD were invited to participate in a pilot BH program. Interested patients were asked to select up to 3 BH goals of interest from a goal elicitation tool (Figure 1). Those who selected at least 1 of the 3 target goals that the BH specialist would focus on were eligible to participate in the telephone-based intervention, which consisted of up to 8, brief, patient-centered sessions, utilizing techniques such as motivational interviewing and mindfulness meditation combined with psychoeducation and supplemental apps/videos. PROs for pain interference (PEG-3), pain catastrophizing, depression/anxiety (PHQ-4) and PROMIS measures of fatigue, quality of life (QoL), physical function, sleep and social satisfaction were collected at baseline and during the final BH session. Depending on the normality of distribution, Wilcoxon signed-rank or student T-tests were used to compare baseline and post-intervention scores.

Results: We enrolled 54 participants, 45 completed the baseline assessment, and 39 engaged in at least 1 BH session beyond baseline. Of these, 28 completed the program (i.e., completed a final assessment session). Among the completers, 79% were women and white. Osteoarthritis (32%), rheumatoid arthritis (21%) and psoriatic arthritis (18%) were the most frequent rheumatologic diagnoses. Fifty percent of the sample had a mental health diagnosis code. Most participants (52%) focused on the goal “Improve My Mood/ Manage Stress & Anxiety” and completed the program in 8 sessions (IQR 6, 8). At baseline (n=28), average PEG-3 score was 3.69/10 and PHQ-4 score was 3.32/12. There was improvement in pre-post mean change scores for PEG-3, pain catastrophizing, PHQ-4, fatigue, sleep and QoL; however, no improvement was noted in social satisfaction or physical function (Table 1).

Conclusion: In this pilot study, recruitment and delivery of an integrated BH program was feasible in a busy rheumatology clinic. We found promising trends toward improvement in PROs for several domains, including pain, pain catastrophizing and depression/anxiety. These results warrant future evaluation with a fully powered randomized controlled trial.

Supporting image 1Figure 1. Goals Wheel. Stars indicate BH services offered.

Supporting image 2Figure 2. Patient Reported Outcomes (PRO) pre-post mean change scores, N&#3f28; *indicates statistical significance


Disclosures: S. Teaw: None; J. Link-Malcolm: None; M. Ghebranious Farag: None; D. Patterson: None; J. Foster: None; S. Bereket: None; U. Wahid: None; P. Bajaj: None; E. Solow: None; J. Barton: None; U. Makris: None.

To cite this abstract in AMA style:

Teaw S, Link-Malcolm J, Ghebranious Farag M, Patterson D, Foster J, Bereket S, Wahid U, Bajaj P, Solow E, Barton J, Makris U. Quantitative Analysis of a Pilot Study: Integrating Behavioral Health Services for Patients with Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/quantitative-analysis-of-a-pilot-study-integrating-behavioral-health-services-for-patients-with-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-analysis-of-a-pilot-study-integrating-behavioral-health-services-for-patients-with-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology